GENENTECH ALLEGED PROTROPIN PHYSICIAN INDUCEMENT OF OFF-LABEL USE UNDER FDA INVESTIGATION; AGENCY HAS LIMITED AUTHORITY OVER FOUNDATIONS, KICKBACKS